New in Nature Nanotechnology: A DNA origami nanosyringe introduces mechanically controlled molecular transport into synthetic cells. This opens new opportunities for synthetic biology, engineered biointerfaces and molecular therapeutics. 

Pulmonary arterial hypertension (PAH) is a rare but life-threatening disease that progressively damages the blood vessels of the lungs and can lead to heart failure. A new review published in the Chinese Medical Journal highlights how advances in genetics, immune biology, and metabolism are transforming scientists' understanding of PAH. By bringing together recent discoveries and emerging therapies, the study suggests that targeting the disease's underlying drivers could pave the way for more effective treatments.

As entropy returns to the scientific spotlight, an Editorial published in Intelligent Medicine proposes a new frame work arguing that critical illness may reflect a breakdown of physiological coordination, and outlines how multimodal data and interpretable AI could help test the idea.

While Parkinson’s disease (PD) involves complex factors, specific genetic causes often remain unknown. In Science Bulletin, a Central South University team identified H6PD as a novel PD causative gene, and found that H6PD mutations damage MAMs, the "bridges" between organelles. This "bridge failure" disables cleanup, causing mitochondrial buildup and neuron death. The study reveals a "H6PD-MAMs-Mitophagy" pathway, offering fresh targets for PD’s precision medicine.

Researchers from the National University of Singapore (NUS) have engineered baker’s yeast to sense and respond to red and blue light. This breakthrough enables scientists to control cell behaviour using light, opening exciting new doors for programmable and predictable biological manufacturing. This is the first time that a single strain of yeast has been engineered to respond to multiple colors of light. Now, the NUS team is boosting its light sensitivity to help produce valuable chemicals and materials.

Bacteria naturally release microscopic particles known as bacterial extracellular vesicles. This review considers how these vesicles could be adapted for precision cancer medicine, from carrying drugs and activating immune responses to limiting metastasis and identifying cancer biomarkers. It also examines the practical obstacles ahead, including inconsistent production, safety risks, contamination and the lack of shared manufacturing and quality standards.

In a new Nature study published on August 10, 2026, Scripps Research scientists developed Dyna-1, a machine learning (ML) model that can predict protein dynamics on the micro-to-millisecond timescale. In seconds, Dyna-1 identifies regions of proteins likely to undergo these movements, revealing aspects of protein function that have remained hidden from conventional computational approaches. Because these micro-to-millisecond dynamics are particularly conserved across biology since they control function, mapping them could help researchers uncover new connections between protein movement and human health.